400-921-8278
| Catalog_no | ADMC0783 |
| Product_name | Altiratinib(DCC-2701) |
| Category | 抑制剂与激动剂 |
| Size | 10mg/50mg/100mg |
| Price | 5560.00/16660.00/23340.00 |
| Specificity | Target: c-Met/HGFR . Fields: Altiratinib is a MET/TIE2/VEGFR2/TRK (A,B,C) kinase inhibitor in Phase 1 clinical development for the treatment of invasive solid tumors including glioblastoma. |
| Purification | >98% |
| Concentration | 靶点：c-Met/HGFR;IC50：No data |
| Storage_stability | 2 years -20°C Powder, 2 weeks4°C in DMSO,6 months-80°C in DMSO |
| othername | Altiratinib, DCC2701,DCC 2701 |
| Observed_band | 510.15 |
| Notes | Altiratinib is a MET/TIE2/VEGFR2/TRK (A,B,C) kinase inhibitor in Phase 1 clinical development for the treatment of invasive solid tumors including glioblastoma. |
| Instructions | 
查看与下载 |
| Share |
 |
Copyright © 2021 苏州博特龙免疫技术有限公司 版权所有 ，苏ICP备2021013855号-1
苏公网安备32050702011981号 
